Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. - Wikidata - wikimedia - TriplyDB

Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.

Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.

http://www.wikidata.org/entity/Q41594930

about

Advances in the management of osteosarcoma Osteosarcoma Overview.Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.Correlation between chemotherapy resistance in osteosarcoma patients and PAK5 and Ezrin gene expression.Team Approach: Osteosarcoma of the Distal Part of the Femur in Adolescents.FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients.Triple primary malignancies of surface osteosarcoma of jaw, myelodysplastic syndrome and colorectal cancer as a second primary cancer detected by PET2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography: A case report.Inhibitory effect of icariin on osteosarcoma cell proliferation via the Wnt/β-catenin signaling pathway.Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma

P2860

Q28067644-45540D1D-65B6-446A-8AC4-FE2D2B15A783 Q33725511-A55EA831-088B-459D-9460-588BA4F7BACD Q47106247-E10A98FF-122E-42A9-9642-594E3F0871B7 Q49178619-774232FC-8232-4F17-9D87-4411216D20B0 Q49572718-40DAF6D5-3843-46B3-96EA-75B12E181DF2 Q50193590-F2631408-1E47-4329-BE76-CABFDCDFE57B Q55193610-48D4628B-EC77-4C27-88B2-AF632EC9E241 Q55622684-2171D4C7-36A5-487A-BC97-D1A852E63F07 Q58739772-1BAEB18C-3198-4C43-948C-BE98A06164E1

P2860

Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.

http://www.wikidata.org/entity/Q41594930

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of (18) F-FDG-PET-C ...... ed and Recurrent Osteosarcoma.

@en

type

label

Comparison of (18) F-FDG-PET-C ...... ed and Recurrent Osteosarcoma.

@en

prefLabel

Comparison of (18) F-FDG-PET-C ...... ed and Recurrent Osteosarcoma.

@en

P1433

Q41594930-2DE59779-CDA2-428E-89B5-A4ED92CE0B9C

P1476

Q41594930-EDC7585F-C30C-4BCF-B5BE-05BBB1672999

P2093

Q41594930-1F0031FC-8F93-40FB-A7D4-34018D36D072

Q41594930-3CCF9025-0C39-4161-8ED7-B9291EEDBBA1

Q41594930-5C03FF24-DF1E-471C-BB7E-21AB8EB48A87

Q41594930-96A0E257-402B-4EFF-9C30-19A29A9F27B1

Q41594930-AC2A374A-F7B0-4552-9F26-53BC7F25BC92

Q41594930-B94335A9-B918-4238-9362-E2309590C2C9

Q41594930-DF2B9E95-5655-47A2-BF71-515A0995A586

Q41594930-F178EFC9-B276-444B-B0F5-11587DF0346C

P2860

Q41594930-0C9F2DFE-3B57-4F3D-98BF-791260428661

Q41594930-0D98579B-9A45-48FC-A4CB-A9855F5D93A2

Q41594930-1969338C-8026-4A0D-BD93-E79EBB7FEA37

Q41594930-44558F80-16C7-41E1-BDBD-29FD0684B5FD

Q41594930-4A1F5CAA-EDFC-4519-B2F8-4B8F245A3D30

Q41594930-50EA221B-B4DF-4528-AE68-3C04651493F0

Q41594930-594EF406-8337-4C5A-8000-8F0C7EEA0E5D

Q41594930-714D4A1D-BEBB-4FDE-A31F-C7DE9373E441

Q41594930-717529D7-91BB-4B3D-AFFA-026D9720C4B0

Q41594930-7E9F36C4-3BE5-4C4C-BB02-33A60B940A70

P304

Q41594930-07B25D31-CD36-41AC-9805-10ECC6FA4AF5

P31

Q41594930-A2F887FD-BD9C-4CFE-ACAE-921EA7B68C65

P356

Q41594930-DD9F4088-7CC5-45BD-9ED7-320937B79082

P433

Q41594930-2843F230-DBDB-4167-8E62-5FD3F964B16F

P478

Q41594930-F0BFC4E9-4841-49BD-A382-34665FC3BCE3

P50

Q41594930-A30A2999-D623-4AC5-A2B9-2B6952D7B1FC

P577

Q41594930-8BDA19CC-1640-4D7E-8859-2F277B97D949

P698

Q41594930-2002A899-6E5B-45DE-B0B2-CC914BBA742E

P932

Q41594930-B7E95223-6148-4A3F-AEF5-680FF7D64FE6

P356

P1433

Pediatric Blood & Cancer

P1476

Comparison of (18) F-FDG-PET-C ...... sed and Recurrent Osteosarcoma

@en

P2093

Alberto S Pappo

http://www.w3.org/2001/XMLSchema#string

Caitlin Hurley

http://www.w3.org/2001/XMLSchema#string

Fariba Navid

http://www.w3.org/2001/XMLSchema#string

Jianrong Wu

http://www.w3.org/2001/XMLSchema#string

M Beth McCarville

http://www.w3.org/2001/XMLSchema#string

Michael W Bishop

http://www.w3.org/2001/XMLSchema#string

Najat C Daw

http://www.w3.org/2001/XMLSchema#string

Shenghua Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Children's Oncology Group's 2013 blueprint for research: bone tumors

Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma

FDG PET imaging of childhood sarcomas.

PET/CT in primary musculoskeletal tumours: a step forward.

Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.

[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults.

Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.

Scintigraphic evaluation of the growth plate.

Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.

P304

1381-1386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.26014

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27082077

http://www.w3.org/2001/XMLSchema#string

P932

5082741

http://www.w3.org/2001/XMLSchema#string